MET and rheumatoid arthritis: Many peripheral diseases, including skeletal muscle injury 54, rheumatoid arthritis 55, autoimmune heart disease 56, and ulcerative colitis 57, exhibit activation of the Met signaling pathway, but there has been contradictory evidence regarding whether it promotes or inhibits inflammation.